Genmab — Juli 2020

[BioShare]

@EL - it was just announced as an equity investment of 20 million euro. And we probably don't know the valuation of Curevac...

[nohope]

Ok, thanks.

[BioShare]

Think its approx 1,42% then...but difficult to have the exact valuation (CureVac was
around EUR1,4 billion in 2017).

[E_L]

Immunomodulatory and clinical effects of daratumumab in T‐cell acute lymphoblastic leukaemia https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16960

[Helge_LarsenPI-redaktør]

Thanks E L. Prematurt - but it looks exciting.

[E_L]

yes, hopefully we'll get some real data from the PhII Delphinus ALL trial before the end of the year

[Stroka]

Sikken en klods i 2330-2331.

[Stroka]

Vupti..Den blev spist.

[Solsen]

Inte5

[Solsen]

Intet kan stoppe Genmab. Husker ikke ATH men er vi ikke tæt på igen ?

[Helge_LarsenPI-redaktør]

3353

[kkjoel]

ATH: 2339 (15.07). ATH-Intraday: 2353 (16.07).

[Solsen]

Så er der langt på

[Solsen]

Tak 2353 kunne godt falde i dag.

[Solsen]

Store daglige udsving må man sige.

[Helge_LarsenPI-redaktør]

Bare det ender opad..er det ok.:-)

[Helge_LarsenPI-redaktør]

Novo, Zeal, Bava ...Flotte stigninger i dag.

[Helge_LarsenPI-redaktør]

Det blev 3337.

[Vitus]

Børsen skulle have lukket 16.30 i dag

[SEACOP]

@Helge 2337 OK for mig